Read + Share
Amedeo Smart
Independent Medical Education
Hummelink K, van der Noort V, Muller M, Schouten RD, et al. Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. PLoS One 2024;19:e0293707.PMID: 39083541
Email
LinkedIn
Privacy Policy